• Progen Pharmaceuticals Ltd.. is located in Brisbane, Australia. The location was incorrect in an item in the Aug. 16 issue.

An article in the Aug. 16 issue of BioWorld Today incorrectly stated that researchers used Elan's anti-amyloid beta antibody bapineuzumab to reduce glaucoma-caused apoptosis in animal studies. The story should have said that the researchers used a research antibody that targets amyloid-beta.

These corrections have been made in BioWorld Online.